Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

M. S. Petersen, M. Strøm, D. Christiansen, Jógvan Páll Fjallsbak, Eina H. Eliasen, Malan Johansen, A. Veyhe, M. F. Kristiansen, S. Gaini, Lars Fodgaard Møller, B. Steig, P. Weihe

Emerging infectious diseases, 2020

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Cited by 21 publications.

Field of study: Medicine

10.3201/eid2611.202736